Research Evidence Comparison# Pemvidutide Research# Key trials include MOMENTUM (Phase 2, obesity, 15.6% weight loss at 48 weeks with 2.4 mg), IMPACT (Phase 2b, MASH, up to 59.1% MASH resolution at 24 weeks, 48-week data showing key measures of success), and RECLAIM (Phase 2, alcohol use disorder, enrolling)
In practical terms, the label says we do not know
Consultation First: When you enquire, a good clinics first question should be about your symptoms and test results
Seek medical advice immediately if you notice any of the following rare but serious side effects of semaglutide: Severe abdominal pain or cramping Significant pain during bowel movements Blood in your stool Persistent nausea and vomiting Vomit that contains blood or that looks like coffee grounds The FDA has also noted some other possible side effects and risks associated with semaglutide